LEADER 01621oam  2200397 a 450 
001 9910702031503321
005 20130117114049.0
035   $a(CKB)5470000002423815
035   $a(OCoLC)808625126
035   $a(EXLCZ)995470000002423815
100   $a20120829d2012      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFederal oversight of high-containment biolaboratories$b[electronic resource] $ehearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, One Hundred Eleventh Congress, first session, September 22, 2009
210  1$aWashington :$cU.S. G.P.O.,$d2012.
215   $a1 online resource (v, 62 pages)
300   $aTitle from title screen (viewed on Aug. 29, 2012).
300   $aPaper version available for sale by the Supt. of Docs., U.S. G.P.O.
300   $a"Serial no. 111-66."
517   $aFederal oversight of high-containment biolaboratories 
606   $aBiological laboratories$zUnited States$xSafety measures
606   $aCommunicable diseases$xResearch$zUnited States$xSafety measures
606   $aBiology$xResearch$zUnited States$xSafety measures
615  0$aBiological laboratories$xSafety measures.
615  0$aCommunicable diseases$xResearch$xSafety measures.
615  0$aBiology$xResearch$xSafety measures.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910702031503321
996   $aFederal oversight of high-containment biolaboratories$93546412
997   $aUNINA